共 264 条
[21]
Vinson C(2000)HMG-CoA reductase inhibitors and the risk of fractures JAMA 283 3205-3210
[22]
Rueger JM(1984)Biased selection of controls for case-control analyses of cohort studies Biometrics 40 63-75
[23]
Karsenty G(1987)Adverse cardiovascular effects of anticholinesterase medications Am J Med Sci 293 18-23
[24]
Karsenty G(2009)Inappropriate medication use and risk of falls—a prospective study in a large community-dwelling elderly cohort BMC Geriatr 9 1-10
[25]
Elefteriou F(2013)Group-based trajectory models: a new approach to classifying and predicting long-term medication adherence Med Care 51 789-796
[26]
Ahn JD(2006)Long-term proton pump inhibitor therapy and risk of hip fracture JAMA 296 2947-2953
[27]
Takeda S(2014)Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS) Osteoporos Int 25 1473-1481
[28]
Starbuck M(2013)Acetylcholinesterase inhibitors and healing of hip fracture in Alzheimer’s disease patients: a retrospective cohort study J Musculoskelet Neuronal Interact 13 454-463
[29]
Yang X(2009)Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study Arch Intern Med 169 867-873
[30]
Liu X(2010)Dementia and hip fractures: development of a pathogenic framework for understanding and studying risk Geriatr Orthop Surg Rehabil 1 52-62